Table 1 Baseline characteristics of AdDIT participants presented overall and by country
Baseline characteristics | Units | Overall | AdDIT International | P | ||
|---|---|---|---|---|---|---|
Australia | Canada | UK | ||||
N | - | 629 | 144 | 312 | 173 |  < 0.0001 |
Demographics | ||||||
 Age | Years | 14.1 ± 1.6 | 13.8 ± 1.5 | 14.3 ± 1.6 | 13.8 ± 1.6 | 0.004 |
 Sex | % Female | 46.8% | 54.9% | 47.1% | 39.5% | 0.025 |
% Male | 53.2% | 45.1% | 52.9% | 60.5% | ||
 Diabetes duration | years | 6.4 ± 3.2 | 6.1 ± 2.7 | 6.6 ± 3.4 | 6.5 ± 3.3 | 0.265 |
 Ethnicity | % White | 78.6% | 93.8% | 59.3% | 95.4% |  < 0.0001 |
% Black | 2.8% | 0.0% | 6.7% | 0.6% | ||
% South Asian | 4.7% | 1.4% | 8.3% | 1.2% | ||
% Chinese | 3.0% | 0.0% | 6.7% | 0.0% | ||
% Aboriginal | 0.4% | 0.7% | 0.3% | 0.0% | ||
% Other | 10.6% | 4.2% | 18.6% | 2.9% | ||
Diabetes management | ||||||
 Insulin regimen | % MDI | 45.9% | 63.2% | 43.9% | 64.9% |  < 0.0001 |
% CSII | 54.1% | 36.8% | 56.1% | 35.1% | ||
 HbA1c | % | 8.5 ± 1.3 | 8.6 ± 1.3 | 8.4 ± 1.3 | 8.4 ± 1.4 | 0.459 |
mmol/mol | 69.2 ± 14.5 | 70.4 ± 14.6 | 69.2 ± 14.0 | 68.2 ± 15.7 | ||
 ACR | mmol/L | 1.54 ± 1.14 | 2.07 ± 1.25 | 1.53 ± 1.21 | 1.11 ± 0.61 |  < 0.0001 |